Edition:
United States

Celldex Therapeutics Inc (CLDX.A)

CLDX.A on American Stock Exchange

2.14USD
12 Aug 2019
Change (% chg)

-- (--)
Prev Close
$2.14
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
350
52-wk High
$9.00
52-wk Low
$2.04

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -1.21 December 17 Aug 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 1 1.26 1.26 1.26 --
Quarter Ending Dec-19 1 1.65 1.65 1.65 --
Year Ending Dec-19 1 5.10 5.10 5.10 6.83
Year Ending Dec-20 1 6.00 6.00 6.00 7.13
Earnings (per share)
Quarter Ending Sep-19 1 -1.21 -1.21 -1.21 --
Quarter Ending Dec-19 1 -1.05 -1.05 -1.05 --
Year Ending Dec-19 1 -3.98 -3.98 -3.98 -8.00
Year Ending Dec-20 1 -3.37 -3.37 -3.37 -8.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-19 1.26 0.71 0.55 43.25
Quarter Ending Mar-19 1.23 1.42 0.19 15.85
Quarter Ending Dec-18 1.46 1.76 0.30 20.82
Quarter Ending Sep-18 1.89 0.94 0.95 50.21
Quarter Ending Jun-18 2.30 2.76 0.47 20.30

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 1.26 1.26 1.26 1.26 --
Quarter Ending Dec-19 1.65 1.65 1.10 1.10 --
Year Ending Dec-19 5.10 5.10 5.10 5.10 6.83
Year Ending Dec-20 6.00 6.00 6.00 6.00 7.13

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-19 0 0 0 0
Quarter Ending Dec-19 0 0 1 0
Year Ending Dec-19 0 0 0 0
Year Ending Dec-20 0 0 0 0
Earnings